-
Signature
-
/s/ Aaron Saltz, attorney-in-fact
-
Issuer symbol
-
MGNI
-
Transactions as of
-
03 Jul 2025
-
Net transactions value
-
-$1,023,627
-
Form type
-
4
-
Filing time
-
08 Jul 2025, 17:20:19 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Soroca Adam Lee |
CHIEF PRODUCT OFFICER |
C/O MAGNITE, INC., 1250 BROADWAY, 15TH FLOOR, NEW YORK |
/s/ Aaron Saltz, attorney-in-fact |
08 Jul 2025 |
0001725125 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
MGNI |
Common Stock |
Options Exercise |
$3.94 |
+2 |
+0% |
$1.97 |
400,929 |
03 Jul 2025 |
Direct |
F1 |
| transaction |
MGNI |
Common Stock |
Options Exercise |
$40,969 |
+8,327 |
+2.1% |
$4.92 |
409,256 |
03 Jul 2025 |
Direct |
F1 |
| transaction |
MGNI |
Common Stock |
Sale |
$1,064,600 |
-42,584 |
-10% |
$25.00 |
366,672 |
03 Jul 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
MGNI |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2 |
-100% |
$0.000000 |
0 |
03 Jul 2025 |
Common Stock |
2 |
$1.97 |
Direct |
F1, F2, F3 |
| transaction |
MGNI |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-8,327 |
-6.4% |
$0.000000 |
121,643 |
03 Jul 2025 |
Common Stock |
8,327 |
$4.92 |
Direct |
F1, F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: